GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AB Science (FRA:A8D) » Definitions » Common Stock

AB Science (FRA:A8D) Common Stock : €0.52 Mil (As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is AB Science Common Stock?

AB Science's quarterly common stock increased from Jun. 2023 (€0.50 Mil) to Dec. 2023 (€0.51 Mil) and increased from Dec. 2023 (€0.51 Mil) to Jun. 2024 (€0.52 Mil).

AB Science's annual common stock stayed the same from Dec. 2021 (€0.47 Mil) to Dec. 2022 (€0.47 Mil) but then increased from Dec. 2022 (€0.47 Mil) to Dec. 2023 (€0.51 Mil).


AB Science Common Stock Historical Data

The historical data trend for AB Science's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AB Science Common Stock Chart

AB Science Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.44 0.46 0.47 0.47 0.51

AB Science Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.47 0.47 0.50 0.51 0.52

AB Science Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


AB Science Business Description

Traded in Other Exchanges
Address
3, Avenue George V, Paris, FRA, 75008
AB Science is a France-based pharmaceutical company specialized in the research, discovery, development, and marketing of protein kinase inhibitors. It is engaged in targeted therapies through tyrosine kinase inhibitors for treating diseases with high medical factor in the field of cancer, chronic inflammatory diseases, neurological degenerative disorders and central nervous systems diseases in both human and veterinary medicine.

AB Science Headlines

No Headlines